0001816736
2020-06-25
2020-09-30
0001816736
2020-09-30
0001816736
2020-06-30
0001816736
us-gaap:CommonClassAMember
2020-09-30
0001816736
us-gaap:CommonClassBMember
2020-09-30
0001816736
us-gaap:CommonClassAMember
2020-06-30
0001816736
us-gaap:CommonClassBMember
2020-06-30
0001816736
2020-07-01
2020-09-30
0001816736
us-gaap:CommonClassAMember
2020-06-25
2020-09-30
0001816736
us-gaap:CommonClassAMember
2020-07-01
2020-09-30
0001816736
us-gaap:CommonClassBMember
2020-06-25
2020-09-30
0001816736
us-gaap:CommonClassBMember
2020-07-01
2020-09-30
0001816736
2020-06-25
2020-06-30
0001816736
us-gaap:IPOMember
2020-08-01
2020-08-11
0001816736
us-gaap:IPOMember
2020-08-01
2020-08-14
0001816736
us-gaap:IPOMember
2020-08-14
0001816736
us-gaap:PrivatePlacementMember
2020-06-25
2020-09-30
0001816736
us-gaap:PrivatePlacementMember
2020-09-30
0001816736
GMTX:LiquidityAndCapitalResourcesMember
2020-06-25
2020-09-30
0001816736
GMTX:LiquidityAndCapitalResourcesMember
2020-09-30
0001816736
us-gaap:OverAllotmentOptionMember
2020-08-01
2020-08-14
0001816736
us-gaap:OverAllotmentOptionMember
2020-08-14
0001816736
GMTX:WorkingCapitalLoanMember
2020-06-25
2020-09-30
0001816736
us-gaap:CommonClassBMember
GMTX:FounderSharesMember
2020-06-25
2020-06-30
0001816736
us-gaap:CommonClassBMember
GMTX:FounderSharesMember
2020-06-30
0001816736
GMTX:FounderSharesMember
2020-07-02
2020-07-24
0001816736
us-gaap:CommonClassBMember
GMTX:FounderSharesMember
2020-08-01
2020-08-11
0001816736
us-gaap:CommonClassBMember
GMTX:FounderSharesMember
2020-08-11
0001816736
2020-08-01
2020-08-11
0001816736
us-gaap:OverAllotmentOptionMember
2020-09-30
0001816736
us-gaap:CommonClassAMember
2020-06-25
2020-06-30
0001816736
us-gaap:OverAllotmentOptionMember
2020-06-25
2020-06-30
0001816736
us-gaap:PrivatePlacementMember
2020-06-30
0001816736
us-gaap:IPOMember
2020-06-25
2020-06-30
0001816736
us-gaap:IPOMember
2020-06-30
0001816736
us-gaap:OverAllotmentOptionMember
2020-06-30
0001816736
us-gaap:SubsequentEventMember
2020-08-01
2020-08-11
0001816736
us-gaap:PrivatePlacementMember
2020-06-25
2020-06-30
0001816736
GMTX:WorkingCapitalLoanMember
2020-06-25
2020-06-30
0001816736
us-gaap:CommonClassBMember
2020-08-11
0001816736
us-gaap:CommonClassBMember
2020-08-01
2020-08-11
0001816736
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2020-10-02
2020-10-15
0001816736
GMTX:FSDevelopmentClassACommonStockMember
us-gaap:SubsequentEventMember
2020-10-02
2020-10-15
0001816736
us-gaap:SubsequentEventMember
2020-10-02
2020-10-15
0001816736
us-gaap:SubsequentEventMember
2020-10-15
0001816736
GMTX:SubscriptionAgreementMember
us-gaap:SubsequentEventMember
2020-10-15
0001816736
GMTX:SubscriptionAgreementMember
us-gaap:SubsequentEventMember
2020-10-02
2020-10-15
0001816736
us-gaap:AdditionalPaidInCapitalMember
2020-06-25
2020-06-30
0001816736
us-gaap:AdditionalPaidInCapitalMember
2020-06-24
0001816736
us-gaap:AdditionalPaidInCapitalMember
2020-09-30
0001816736
us-gaap:AdditionalPaidInCapitalMember
2020-06-30
0001816736
us-gaap:RetainedEarningsMember
2020-06-25
2020-06-30
0001816736
us-gaap:RetainedEarningsMember
2020-06-24
0001816736
us-gaap:RetainedEarningsMember
2020-09-30
0001816736
us-gaap:RetainedEarningsMember
2020-06-30
0001816736
2020-06-24
0001816736
us-gaap:CommonClassAMember
2020-06-24
0001816736
us-gaap:CommonClassBMember
2020-06-25
2020-06-30
0001816736
us-gaap:CommonClassBMember
2020-06-24
0001816736
us-gaap:CommonClassAMember
us-gaap:IPOMember
2020-06-25
2020-06-30
0001816736
us-gaap:AdditionalPaidInCapitalMember
2020-07-01
2020-09-30
0001816736
us-gaap:RetainedEarningsMember
2020-07-01
2020-09-30
0001816736
us-gaap:IPOMember
2020-06-25
2020-09-30
0001816736
us-gaap:IPOMember
2020-09-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
S-1
false
Gemini Therapeutics, Inc. /DE
0001816736
Non-accelerated Filer
true
true
false
DE
1437928
25000
53000
122358987
78000
461999
54500
552402
54500
5500488
24698
-500911
-1500
5000005
23500
126
302
302
5500488
24698
-500911
-1500
122358987
78000
169570
1607498
120751489
40489
49914
4226250
4778652
112580330
126
0.0001
0.0001
1000000
1000000
0.0001
0.0001
0.0001
0.0001
0.0001
100000000
10000000
100000000
10000000
1258467
3018750
3018750
1258467
3018750
3018750
3018750
0.0001
11258033
10.00
-500911
-499411
-1500
-500911
-499411
1489
1489
-502400
-500900
49914
49914
452486
450986
1500
12516500
12516500
3018750
3018750
-0.17
-0.17
-0.00
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 — Description of Organization, Business Operations and Basis of Presentation</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">FSDC
(the "Company") is a blank check company incorporated in Delaware on June 25, 2020. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses. The Company is an emerging growth company and, as such, the Company is subject to all of the risks
associated with emerging growth companies.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2020, the Company had not commenced any operations. All activity for the period from June 25, 2020 (inception)
through September 30, 2020 relates to the Company's formation and the initial public offering ("Initial Public Offering")
and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will
not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company
will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from
the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company's sponsor is FSDC Holdings, LLC, a Delaware limited liability company (the "Sponsor"). The registration
statement for the Company's Initial Public Offering became effective on August 11, 2020. On August 14, 2020, the Company
consummated its Initial Public Offering of 12,075,000 shares of Class A common stock, including the issuance of 1,575,000 shares
of Class A Common Stock as a result of the underwriter's exercise in full of its over-allotment option, (each, a "Public
Share" and collectively, the "Public Shares") at $10.00 per share, generating gross proceeds of approximately
$120.8 million, and incurring offering costs of approximately $7.1 million, inclusive of approximately $4.2 million in deferred
underwriting commissions (Note 5).</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the private placement ("Private Placement")
of 441,500 shares of Class A common stock (each, a "Private Placement Share" and collectively, the "Private
Placement Shares"), at a price of $10.00 per Private Placement Share to the Sponsor, generating proceeds of approximately
$4.4 million (Note 4).</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
the Closing of the Initial Public Offering and the Private Placement, approximately $120.8 million ($10.00 per share) of the net
proceeds of the sale of the Public Shares in the Initial Public Offering and of the Private Placement Shares in the Private Placement
were placed in a trust account ("Trust Account") located in the United States at JP Morgan Chase Bank, N.A. with Continental
Stock Transfer & Trust Company acting as trustee, and are invested only in U.S. "government securities" within
the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury
obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution
of the Trust Account as described below.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public
Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination
successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at
least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital
purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into
the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company
owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target
sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended
(the "Investment Company Act").</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company will provide the holders (the "Public Stockholders") of the Company's outstanding Public Shares with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in
connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision
as to whether the Company will seek stockholder approval of a Business Combination or conduct a</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">tender
offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares
for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share). The
per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting
commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be recorded at a redemption
value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting
Standards Board's ("FASB") Accounting Standards Codification ("ASC") Topic 480 "Distinguishing
Liabilities from Equity." The Company will proceed with a Business Combination if a majority of the shares voted are voted
in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible
assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder
vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation
(the "Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing a Business Combination.
If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval
for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the
proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public
Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in
connection with a Business Combination, the Initial Stockholders (as defined below) have agreed to vote their Founder Shares (as
defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination.
In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public
Shares in connection with the completion of a Business Combination.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other
person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect
to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Sponsor and the Company's officers and directors (the "Initial Stockholders") have agreed not to propose an
amendment to the Certificate of Incorporation to modify the substance or timing of the Company's obligation to redeem 100%
of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below)
or with respect to any other material provisions relating to stockholders' rights or pre-initial Business Combination activity,
unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any
such amendment.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">If
the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or
August 14, 2022 (the "Combination Period"), the Company will (i) cease all operations except for the purpose of winding
up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds
held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay
dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public
Stockholders' rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board
of directors, liquidate and dissolve, subject in each case to the Company's obligations under Delaware law to provide for
claims of creditors and the requirements of other applicable law.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the
Founder Shares and Private Placement Shares if the Company fails to complete a Business Combination within the Combination Period.
However, if the Initial Stockholders acquire Public Shares on or after the Initial Public Offering, they will be entitled to liquidating
distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination
within the Combination Period. The underwriters have agreed</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">to
waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does
not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other
funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets)
will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company
if and to the extent any claims by a third party (except for the Company's independent registered public accounting firm)
for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into
a letter of intent, confidentiality or other similar agreement or business combination agreement (a "Target"), reduce
the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public
Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due
to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims
by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not
such waiver is enforceable) nor will it apply to any claims under the Company's indemnity of the underwriters of the Initial
Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities
Act"). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to
claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with
which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in
or to monies held in the Trust Account.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Business
Combination</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 15, 2020, the Company entered into an agreement and plan of merger (the "Merger Agreement") by and among the
Company, FSG Merger Sub Inc., a Delaware corporation, Gemini Therapeutics, Inc., a Delaware corporation ("Gemini")
and Shareholder Representative Services LLC, a Colorado limited liability company, in its capacity as the representative, agent
and attorney-in-fact of the securityholders of Gemini (in such capacity, the "Stockholders' Representative").
The Merger Agreement provides, among other things, that Merger Sub will merge with and into Gemini, with Gemini surviving as a
wholly owned subsidiary of the Company. See Note 7.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Basis
of Presentation</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally
accepted accounting principles ("U.S. GAAP") for interim financial information and Article 8 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments
(consisting of normal accruals) considered for a fair presentation have been included. Operating results for the period from June
25, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected for the period
ending December 31, 2020.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and
notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on August 20, 2020 and August
13, 2020, respectively.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Emerging
Growth Company</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute
payments not previously approved.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition
period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable.
The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised
and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt
the new or revised standard at the time private companies adopt the new or revised standard.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">This
may make comparison of the Company's financial statements with another public company that is neither an emerging growth
company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because
of the potential differences in accounting standards used.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Liquidity
and Capital Resources</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2020, the Company had $1.4 million in its operating bank account, working capital of approximately $1.1 million
and cash equivalents held in the Trust Account of approximately $120.8 million. Interest income on the balance in the Trust Account
may be used to pay the Company's franchise and income tax obligations. Through September 30, 2020, the Company has not withdrawn
any interest earned on the Trust Account to pay franchise and income tax obligations. Management intends to use substantially
all of the funds held in the Trust Account to complete the initial Business Combination and to pay the Company's expenses
relating thereto. To the extent that the Company's capital stock or debt is used, in whole or in part, as consideration
to complete the initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital
to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company's liquidity needs to date have been satisfied through the $25,000 capital contribution to purchase Founder Shares
(as defined below) by the Sponsor, the loan proceeds under the Note of $200,000 from the Sponsor (see Note 4) to the Company to
cover offering costs in connection with the Initial Public Offering, and the net proceeds from the consummation of the Private
Placement not held in the Trust Account. The Note was fully repaid on August 14, 2020. In addition, in order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's
officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of September
30, 2020, there were no amounts outstanding under any Working Capital Loans.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Based
on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor
or an affiliate of the Sponsor, or certain of the Company's officers and directors to meet its needs through the earlier
of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these
funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing
due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or
acquire, and structuring, negotiating and consummating the Business Combination.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable
as of the date of the balance sheet. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 1 — Description of Organization, Business Operations
and Basis of Presentation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">FSDC (the "Company") is a blank
check company incorporated in Delaware on June 25, 2020. The Company was formed for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth
companies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">As of June 30, 2020, the Company had not
commenced any operations. All activity for the period from June 25, 2020 (inception) through June 30, 2020 relates to the Company's
formation and the proposed initial public offering described below. The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the
form of interest income on cash and cash equivalents from the proceeds derived from the Proposed Public Offering (as defined below).
The Company has selected December 31 as its fiscal year end.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company's sponsor is FSDC Holdings,
LLC, a Delaware limited liability company (the "Sponsor"). The Company's ability to commence operations is contingent
upon obtaining adequate financial resources through a proposed public offering (the "Proposed Public Offering") of
10,500,000 shares of Class A common stock (each, a "Public Share" and collectively, the "Public Shares")
at $10.00 per share (or 12,075,000 shares if the underwriters' over-allotment option is exercised in full), which is discussed
in Note 3, and the sale of 410,000 shares of Class A common stock (or 441,500 shares if the underwriters' over-allotment
option is exercised in full) (each, a "Private Placement Share" and collectively, the "Private Placement Shares"),
at a price of $10.00 per Private Placement Share in a private placement to the Sponsor that will close simultaneously with the
Proposed Public Offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company's management has broad
discretion with respect to the specific application of the net proceeds of the Proposed Public Offering and the sale of Private
Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business
Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must
complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held
in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the
amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination.
However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of
the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required
to register as an investment company under the Investment Company Act 1940, as amended (the "Investment Company Act").
At the Closing of the Proposed Public Offering, management has agreed that an amount equal to at least $10.00 per share sold in
the Proposed Public Offering, including the proceeds from the sale of the Private Placement Shares to the Sponsor, will be held
in a trust account ("Trust Account") located in the United States at JP Morgan Chase Bank, N.A. with Continental Stock
Transfer & Trust Company acting as trustee, and invested only in U.S. "government securities" within the meaning
of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain
conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations,
as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the
Trust Account as described below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company will provide the holders (the
"Public Stockholders") of the Company's outstanding Public Shares with the opportunity to redeem all or a portion
of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called
to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public
Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account
(initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Stockholders who redeem
their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed
in Note 5). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of
the Proposed Public Offering in accordance with the Financial Accounting Standards Board's ("FASB")</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Accounting Standards Codification ("ASC")
Topic 480 "Distinguishing Liabilities from Equity." The Company will proceed with a Business Combination if a majority
of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount
that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company
does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated
Certificate of Incorporation (the "Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer
rules of the U.S. Securities and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to
completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides
to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy
solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may
elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks
stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) have agreed to vote
their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Proposed Public Offering
in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect
to their Founder Shares and Public Shares in connection with the completion of a Business Combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Certificate of Incorporation will provide
that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting
in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public
Shares, without the prior consent of the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Sponsor and the Company's officers
and directors (the "Initial Stockholders") have agreed not to propose an amendment to the Certificate of Incorporation
to modify the substance or timing of the Company's obligation to redeem 100% of the Public Shares if the Company does not
complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions
relating to stockholders' rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders
with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">If the Company is unable to complete a
Business Combination within 24 months from the closing of the Proposed Public Offering (the "Combination Period"),
the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not
more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of
then outstanding Public Shares, which redemption will completely extinguish Public Stockholders' rights as stockholders (including
the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case
to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of other applicable
law.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Initial Stockholders have agreed to
waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement
Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders
acquire Public Shares in or after the Proposed Public Offering, they will be entitled to liquidating distributions from the Trust
Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period.
The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account
in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts
will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares.
In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution
(including Trust Account assets) will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has
agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company's independent
registered public accounting firm) for services rendered or</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">products sold to the Company, or a prospective
target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business
combination agreement (a "Target"), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00
per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the
Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided
that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the
monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company's
indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities
Act of 1933, as amended (the "Securities Act"). The Company will seek to reduce the possibility that the Sponsor will
have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective
target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right,
title, interest or claim of any kind in or to monies held in the Trust Account.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Basis of Presentation</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The accompanying financial statements are
presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America ("U.S.
GAAP") and pursuant to the rules and regulations of the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company does not have sufficient liquidity
to meet its anticipated obligations over the next year from the issuance of these financial statements. In connection with the
Company's assessment of going concern considerations in accordance with FASB's Accounting Standards Update ("ASU")
2014-15, "Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has
determined that the Company has access to funds from the Sponsor that are sufficient to fund the working capital needs of the Company
until the earlier of the consummation of the Proposed Public Offering or one year from the issuance of these financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company is an "emerging growth
company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012
(the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with
the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private
companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of
securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The
JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to
opt out of such extended transition period, which means that when a standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the
time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements
with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using
the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p>
The registration statement for the Company’s Initial Public Offering became effective on August 11, 2020.
441500
12075000
441500
12075000
10500000
120800000
1575000
3018750
1575000
10.00
12.00
10.00
10.00
10.00
10.00
10.00
120750000
120800000
4400000
120800000
7100000
4200000
The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).
10.00
10.00
5000001
5000001
1.00
1.00
0.20
0.20
100000
100000
10.00
10.00
(i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
(i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
1400000
1100000
120800000
25000
200000
200000
200000
0.50
0.50
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 — Summary of Significant Accounting Policies</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Use
of Estimates</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably
possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial
statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming
events. Accordingly, the actual results could differ significantly from those estimates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
and Cash Equivalents</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had approximately $120.8 million in cash equivalents held in the Trust Account as of September 30, 2020.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
Equivalents Held in Trust Account</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
the Closing of the Initial Public Offering and the Private Placement, the Company was required to place net proceeds of the Initial
Public Offering and certain of the proceeds of the Private Placement in a Trust Account, which may be invested in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less,
or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest
only in direct U.S. government treasury obligations, as determined by management of the Company, until the earlier of: (i) the
completion of a Business Combination and (ii) the distribution of the Trust Account.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
the Closing of the Initial Public Offering and the Private Placement, approximately $120.8 million, was placed in the Trust Account
and invested in money market funds that invest in U.S. government securities. All of the Company's investments held in the
Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the
end of each reporting period. The estimated fair values of investments held in Trust Account are determined using available market
information, other than for investments in open-ended money market funds with published daily net asset values ("NAV"),
in which case the Company uses NAV as a practical expedient to fair value. The NAV on these investments is typically held constant
at $1.00 per unit.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Concentration
of Credit Risk</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At September
30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant
risks on such accounts.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value of Financial Instruments</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes
the inputs used in measuring fair value.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
1, defined as observable inputs such as quoted prices for identical instruments in active markets;</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not
active; and</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are
unobservable.</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy.
In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest
level input that is significant to the fair value measurement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2020, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to
the short-term nature of the instruments. As of September 30, 2020, the Company's portfolio of investments held in the Trust
Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses
NAV as a practical expedient to fair value for its investments in money market funds.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Offering
Costs Associated with the Initial Public Offering</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Offering
costs consisted of legal, accounting, and other costs incurred that were directly related to the Initial Public Offering and that
were charged to stockholders' equity upon the completion of the Initial Public Offering.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Class
A Common Stock Subject to Possible Redemption</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480
"Distinguishing Liabilities from Equity." Class A common stock subject to mandatory redemption (if any) is classified
as a liability instrument and measured at fair value. Conditionally redeemable Class A common stock (including Class A common
stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, Class
A common stock is classified as stockholders' equity. The Company's Class A common stock features certain redemption
rights that are considered to be outside of the Company's control and subject to the occurrence of uncertain future events.
Accordingly, at September 30, 2020, 11,258,033 Class A common stock subject to possible redemption is presented as temporary equity,
outside of the stockholders' equity section of the Company's unaudited condensed balance sheet.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Income
Taxes</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized
for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized. As of September 30, 2020, the Company had a deferred tax asset of approximately $105,000, which had a full valuation
allowance recorded against it of approximately $105,000. The deferred tax asset is comprised of $95,000 of organization and start-up
costs and $10,000 of projected net operating loss for the current tax year.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
tax benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related
to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September
30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or
material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Net
Income (Loss) Per Common Share</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Net
income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common stock outstanding during
the periods. The Company's unaudited condensed statements of operations include a presentation of income (loss) per share
for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss)
per common share, basic and diluted for Class A common stock is calculated by dividing the interest earned on cash equivalents
held in the Trust Account of approximately $1,000 for the three months ended September 30, 2020 and for the period from June 25,
2020 (inception) through September 30, 2020, net of applicable taxes available to be withdrawn from the Trust Account of approximately
$1,000 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020,
resulting in net income of $0 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception)
through September 30, 2020, by the weighted average number of Class A common stock outstanding for each period. Net loss per share,
basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $499,000 and $501,000 for the
three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, respectively,
less income attributable to Class A common stock of $0 for each period, by the weighted average number of Class B common stock
outstanding for the period.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any recently issued, but not yet effective, accounting pronouncement if currently adopted would have a material
effect on the Company's financial statements.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 2 — Summary of Significant Accounting Policies</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Financial instruments that potentially
subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may
exceed the Federal Depository Insurance Coverage limit of $250,000. At June 30, 2020, the Company has not experienced losses on
these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Financial Instruments</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The fair value of the Company's assets
and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurements and Disclosures,"
approximates the carrying amounts represented in the balance sheet.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Use of Estimates</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of financial statements
in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and
the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Deferred Offering Costs Associated with the Proposed Public
Offering</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Deferred offering costs consist of legal,
accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Proposed
Public Offering and that will be charged to stockholder's equity upon the completion of the Proposed Public Offering. Should
the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will
be charged to operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Net Loss Per Common Share</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company complies with accounting and
disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net
loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to
forfeiture. Weighted average shares at June 30, 2020 were reduced for the effect of an aggregate of 393,750 shares of Class B common
stock that are subject to forfeiture by our sponsor if the over-allotment option is not exercised in full or in part by the underwriters
(see Note 6). At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be
exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per
share is the same as basic loss per share for the period presented.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Income Taxes</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company follows the asset and liability
method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized
for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized. Deferred tax assets were deemed immaterial as of June 30, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">FASB ASC 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination
by taxing authorities. There were no unrecognized tax benefits as of June 30, 2020. The Company recognizes accrued interest and
penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">as of June 30, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was
deemed to be de minimis for the period from June 25, 2020 (inception) through June 30, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company's management does not
believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect
on the accompanying financial statements.</p>
120800000
120800000
1.00
250000
250000
11258033
105000
105000
95000
10000
Trust Account of approximately $1,000 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, net of applicable taxes available to be withdrawn from the Trust Account of approximately $1,000 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, resulting in net income of $0 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, by the weighted average number of Class A common stock outstanding for each period. Net loss per share, basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $499,000 and $501,000 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, respectively, less income attributable to Class A common stock of $0 for each period, by the weighted average number of Class B common stock outstanding for the period.
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Use
of Estimates</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably
possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial
statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming
events. Accordingly, the actual results could differ significantly from those estimates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Use of Estimates</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of financial statements
in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and
the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
and Cash Equivalents</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had approximately $120.8 million in cash equivalents held in the Trust Account as of September 30, 2020.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
Equivalents Held in Trust Account</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
the Closing of the Initial Public Offering and the Private Placement, the Company was required to place net proceeds of the Initial
Public Offering and certain of the proceeds of the Private Placement in a Trust Account, which may be invested in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less,
or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest
only in direct U.S. government treasury obligations, as determined by management of the Company, until the earlier of: (i) the
completion of a Business Combination and (ii) the distribution of the Trust Account.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
the Closing of the Initial Public Offering and the Private Placement, approximately $120.8 million, was placed in the Trust Account
and invested in money market funds that invest in U.S. government securities. All of the Company's investments held in the
Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the
end of each reporting period. The estimated fair values of investments held in Trust Account are determined using available market
information, other than for investments in open-ended money market funds with published daily net asset values ("NAV"),
in which case the Company uses NAV as a practical expedient to fair value. The NAV on these investments is typically held constant
at $1.00 per unit.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Concentration
of Credit Risk</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At September
30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant
risks on such accounts.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Financial instruments that potentially
subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may
exceed the Federal Depository Insurance Coverage limit of $250,000. At June 30, 2020, the Company has not experienced losses on
these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value of Financial Instruments</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes
the inputs used in measuring fair value.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
1, defined as observable inputs such as quoted prices for identical instruments in active markets;</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not
active; and</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">●</font></td><td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are
unobservable.</font></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy.
In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest
level input that is significant to the fair value measurement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2020, the carrying values of cash, accounts payable and accrued expenses approximate their fair values due to
the short-term nature of the instruments. As of September 30, 2020, the Company's portfolio of investments held in the Trust
Account is comprised entirely of investments in money market funds that invest in U.S. government securities. The Company uses
NAV as a practical expedient to fair value for its investments in money market funds.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Financial Instruments</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The fair value of the Company's assets
and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurements and Disclosures,"
approximates the carrying amounts represented in the balance sheet.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Offering
Costs Associated with the Initial Public Offering</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Offering
costs consisted of legal, accounting, and other costs incurred that were directly related to the Initial Public Offering and that
were charged to stockholders' equity upon the completion of the Initial Public Offering.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Deferred Offering Costs Associated with the Proposed Public
Offering</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Deferred offering costs consist of legal,
accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Proposed
Public Offering and that will be charged to stockholder's equity upon the completion of the Proposed Public Offering. Should
the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will
be charged to operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Class
A Common Stock Subject to Possible Redemption</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480
"Distinguishing Liabilities from Equity." Class A common stock subject to mandatory redemption (if any) is classified
as a liability instrument and measured at fair value. Conditionally redeemable Class A common stock (including Class A common
stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, Class
A common stock is classified as stockholders' equity. The Company's Class A common stock features certain redemption
rights that are considered to be outside of the Company's control and subject to the occurrence of uncertain future events.
Accordingly, at September 30, 2020, 11,258,033 Class A common stock subject to possible redemption is presented as temporary equity,
outside of the stockholders' equity section of the Company's unaudited condensed balance sheet.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Income
Taxes</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized
for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized. As of September 30, 2020, the Company had a deferred tax asset of approximately $105,000, which had a full valuation
allowance recorded against it of approximately $105,000. The deferred tax asset is comprised of $95,000 of organization and start-up
costs and $10,000 of projected net operating loss for the current tax year.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
tax benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related
to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September
30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or
material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Income Taxes</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company follows the asset and liability
method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized
for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized. Deferred tax assets were deemed immaterial as of June 30, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">FASB ASC 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination
by taxing authorities. There were no unrecognized tax benefits as of June 30, 2020. The Company recognizes accrued interest and
penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">as of June 30, 2020. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was
deemed to be de minimis for the period from June 25, 2020 (inception) through June 30, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Net
Income (Loss) Per Common Share</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Net
income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common stock outstanding during
the periods. The Company's unaudited condensed statements of operations include a presentation of income (loss) per share
for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss)
per common share, basic and diluted for Class A common stock is calculated by dividing the interest earned on cash equivalents
held in the Trust Account of approximately $1,000 for the three months ended September 30, 2020 and for the period from June 25,
2020 (inception) through September 30, 2020, net of applicable taxes available to be withdrawn from the Trust Account of approximately
$1,000 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020,
resulting in net income of $0 for the three months ended September 30, 2020 and for the period from June 25, 2020 (inception)
through September 30, 2020, by the weighted average number of Class A common stock outstanding for each period. Net loss per share,
basic and diluted for Class B common stock is calculated by dividing the net loss of approximately $499,000 and $501,000 for the
three months ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020, respectively,
less income attributable to Class A common stock of $0 for each period, by the weighted average number of Class B common stock
outstanding for the period.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Net Loss Per Common Share</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company complies with accounting and
disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net
loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to
forfeiture. Weighted average shares at June 30, 2020 were reduced for the effect of an aggregate of 393,750 shares of Class B common
stock that are subject to forfeiture by our sponsor if the over-allotment option is not exercised in full or in part by the underwriters
(see Note 6). At June 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be
exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per
share is the same as basic loss per share for the period presented.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
does not believe that any recently issued, but not yet effective, accounting pronouncement if currently adopted would have a material
effect on the Company's financial statements.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company's management does not
believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect
on the accompanying financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 — Initial Public Offering</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 14, 2020, the Company consummated its Initial Public Offering of 12,075,000 Public Shares, including the issuance of 1,575,000
Public Shares as a result of the underwriter's exercise in full of its over-allotment option, at $10.00 per share, generating
gross proceeds of approximately $120.8 million, and incurring offering costs of approximately $7.1 million, inclusive of approximately
$4.2 million in deferred underwriting commissions.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 3 — Proposed Public Offering</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Pursuant to the Proposed Public Offering,
the Company intends to offer for sale 10,500,000 shares of Class A Common stock at a price of $10.00 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company will grant the underwriters
a 45-day option from the date of the final prospectus relating to the Proposed Public Offering to purchase up to 1,575,000 additional
shares to cover over-allotments, if any, at the Proposed Public Offering price, less underwriting discounts and commissions.</p>
12075000
410000
441500
10500000
10.00
10.00
10.00
7100000
4200000
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 — Related Party Transactions</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Founder
Shares and Private Placement Shares</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
June 30, 2020, the Sponsor purchased 2,875,000 shares of the Company's Class B common stock, par value $0.0001 per share,
(the "Founder Shares") for an aggregate price of $25,000. On July 24, 2020, the Sponsor transferred 30,000 Founder
Shares to each of its independent director nominees at their original per-share purchase price, for an aggregate of 90,000 Founder
Shares transferred. On August 11, 2020, the Company effected a 1:1.05 stock split of the Class B common stock, resulting in the
Sponsor holding an aggregate of 2,928,750 Founder Shares and there being an aggregate of 3,018,750 Founder Shares outstanding.
All shares and the associated amounts have been retroactively restated to reflect the aforementioned stock split. The Sponsor
agreed to forfeit up to 393,750 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriter,
so that the Founder Shares would represent 20.0% of the Company's issued and outstanding shares of common stock after the
Initial Public Offering (excluding the Private Placement Shares). On August 14, 2020, the underwriter exercised the over-allotment
option; thus, these Founder Shares were no longer subject to forfeiture.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the Private Placement of 441,500 Private Placement Shares,
at a price of $10.00 per Private Placement Share to the Sponsor, generating proceeds of approximately $4.4 million.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares or Private
Placement Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii)
the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial
Business Combination that results in all of the Company's stockholders having</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">the
right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and
under certain circumstances. Any permitted transferees will be subject to the same restrictions and other agreements of the Initial
Stockholders with respect to any Founder Shares or Private Placement Shares. Notwithstanding the foregoing, if (1) the closing
price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the
initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results
in the Company's stockholders having the right to exchange their shares for cash, securities or other property, the Founder
Shares and Private Placement Shares will be released from the lock-up.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Related
Party Loans</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
June 30, 2020, the Sponsor agreed to loan the Company an aggregate of up to $200,000 to cover expenses related to the Initial
Public Offering pursuant to a promissory note (the "Note"). This loan is non-interest bearing and payable upon the
completion of the Initial Public Offering. The Company borrowed $200,000 under the Note, and fully repaid it on August 14, 2020.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the
Sponsor, or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may
be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company would repay the
Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would
be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust
Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of
a Business Combination or, at the lender's discretion, up to $1.5 million of such Working Capital Loans may be convertible
into shares of Class A Common Stock of the post Business Combination entity at a price of $10.00 per share. Except for the foregoing,
the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such
loans. To date, the Company had no borrowings under the Working Capital Loans.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Private
Placement of Common Stock in connection with initial Business Combination</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Sponsor has indicated an interest to purchase $25.0 million of the Company's Class A Common Stock in a private placement
that would occur concurrently with the consummation of the initial Business Combination. The funds from such private placement
would be used as part of the consideration to the sellers in the initial Business Combination, and any excess funds from such
private placement would be used for working capital in the post-transaction company. However, because indications of interest
are not binding agreements or commitments to purchase, the Sponsor may determine not to purchase any such shares, or to purchase
fewer shares than it indicated an interest in purchasing. Furthermore, the Company is not under any obligation to sell any such
shares.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Administrative
Services Agreement</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into an agreement that provides that, commencing on the date that the Company's securities are first
listed on Nasdaq and continuing until the earlier of the Company's consummation of a Business Combination and the Company's
liquidation, the Company will pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services
provided to members of the Company's management team. The Company incurred approximately $20,000 in administrative expenses
under the agreement, which is recognized in the accompanying unaudited condensed statements of operations for both the three months
ended September 30, 2020 and for the period from June 25, 2020 (inception) through September 30, 2020 within general and administrative
expense.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred
in connection with activities on the Company's behalf such as identifying potential target businesses and performing due
diligence on suitable Business Combinations. The Company's audit committee will review on a quarterly basis all payments
that were made to the Sponsor, officers or directors, or their affiliates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Proposed
Business Combination</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the execution of the Merger Agreement, the Sponsor entered into a subscription agreement to purchase 1,500,000
shares of Class A Common Stock at a purchase price of $10 per share in a private placement that would occur concurrently with
the closing of the Merger (the "Closing"). In addition, the Initial Stockholders entered into the Parent Support Agreement
in which they agreed to vote, at any meeting of the stockholders of the Company, and in any action by written consent of the stockholders
of the Company, all of such holders' Class A common stock and Class B common stock (i) in favor of the Merger Agreement,
each of the Parent Proposals (as defined in the Merger Agreement) and the transactions contemplated by the Merger Agreement and
the Parent Support Agreement, and (ii) in favor of any other matter reasonably necessary to the consummation of the transactions
contemplated by the Merger Agreement and the approval of the Parent Proposals. Also, in connection with the Closing, the Sponsor
and certain other stockholders will enter into a Voting Agreement with the Company and the Initial Stockholders and certain other
stockholders will enter into a Registration Rights Agreement with the Company. See Note 7 for a discussion of certain agreements
entered into, or to be entered into, in connection with the execution of the Merger Agreement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 4 — Related Party Transactions</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Founder Shares</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On June 30, 2020, the Sponsor purchased
2,875,000 shares of the Company's Class B common stock, par value $0.0001 per share, (the "Founder Shares") for
an aggregate price of $25,000. On July 24, 2020, the Sponsor transferred 30,000 Founder Shares to each of its independent director
nominees at their original per-share purchase price, for an aggregate of 90,000 Founder Shares transferred. On August 11, 2020,
the Company effected a 1:1.05 stock split of the Class B common stock, resulting in the Sponsor holding an aggregate of 2,928,750
Founder Shares and there being an aggregate of 3,018,750 Founder Shares outstanding. All shares and the associated amounts have
been retroactively restated to reflect the aforementioned stock split. The Sponsor has agreed to forfeit up to 393,750 Founder
Shares to the extent that the over-allotment option is not exercised in full by the underwriters. The forfeiture will be adjusted
to the extent that the over-allotment option is not exercised in full by the underwriters so that the Founder Shares will represent
20.0% of the Company's issued and outstanding shares of common stock after the Proposed Public Offering (excluding the Private
Placement Shares).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Sponsor has agreed to purchase an aggregate
of 410,000 Private Placement Shares (or 441,500 Private Placement Shares if the underwriters' over-allotment option is exercised
in full), at a price of $10.00 per Private Placement Share ($4,100,000 in the aggregate, or $4,415,000 if the underwriters'
over-allotment option is exercised in full) in a private placement that will occur simultaneously with the closing of the Proposed
Public Offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Initial Stockholders has agreed, subject
to limited exceptions, not to transfer, assign or sell any of the Founder Shares or Private Placement Shares until the earlier
to occur of: (i) one year after the completion of the initial Business Combination and (ii) the date on which the Company completes
a liquidation, merger, capital stock exchange or other similar transaction after our initial Business Combination that results
in all of the Company's stockholders having the right to exchange their Class A common stock for cash, securities or other
property; except to certain permitted transferees and under certain circumstances. Any permitted transferees will be subject to
the same restrictions and other agreements of the Initial Stockholders with respect to any Founder Shares or Private Placement
Shares. Notwithstanding the foregoing, if (1) the closing price of the Class A common stock equals or exceeds $12.00 per share
(as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days
within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates
a transaction after the initial Business Combination which results in the Company's stockholders having the right to exchange
their shares for cash, securities or other property, the Founder Shares and Private Placement Shares will be released from the
lock-up.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Related Party Loans</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On June 30, 2020, the Sponsor agreed to
loan the Company an aggregate of up to $200,000 to cover expenses related to the Proposed Public Offering pursuant to a promissory
note (the "Note"). This loan is non-interest bearing and payable on the earlier of December 31, 2020 or the completion
of the Proposed Public Offering. As of June 30, 2020, the Company has not borrowed any amount under the Note. Subsequent to June
30, 2020, the Company received $200,000 in loan proceeds under the Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">In addition, in order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's
officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans").
If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust
Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust
Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust
Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital
Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender's discretion,
up to $1.5 million of such Working Capital Loans may be convertible into shares of Class A Common Stock of the post Business Combination
entity at a price of $10.00 per share. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been
determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working
Capital Loans.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Private Placement of Common Stock in connection with initial
Business Combination</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Sponsor has indicated an interest to
purchase $25.0 million of the Company's Class A Common Stock in a private placement that would occur concurrently with the
consummation of the initial Business Combination. The funds from such private placement would be used as part of the consideration
to the sellers in the initial Business Combination, and any excess funds from such private placement would be used for working
capital in the post-transaction company. However, because indications of interest are not binding agreements or commitments to
purchase, the Sponsor may determine not to purchase any such shares, or to purchase fewer shares than it indicated an interest
in purchasing. Furthermore, the Company is not under any obligation to sell any such shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Administrative Services Agreement</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company has entered into an agreement
that provides that, commencing on the date that the Company's securities are first listed on Nasdaq and continuing until
the earlier of the Company's consummation of a Business Combination and the Company's liquidation, the Company will
pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to members of the
Company's management team.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Sponsor, officers and directors, or
any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on
the Company's behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations.
The Company's audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors,
or their affiliates.</p>
200000
200000
25000000
25000000
1500000
1500000
10.00
10.00
10000
10000
20000
1500000
10
2875000
441500
410000
25000
4415000
4100000
2928750
393750
393750
0.20
0.20
441500
4400000
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 — Commitments and Contingencies</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Registration
Rights</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
holders of Founder Shares and Private Placement Shares that may be issued upon conversion of Working Capital Loans, if any, will
be entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to
make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have
certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion
of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Underwriting
Agreement</i></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
underwriter was entitled to an underwriting discount of $0.20 per share, or approximately $2.4 million in the aggregate, paid
at the Closing of the Initial Public Offering. In addition, $0.35 per share, or approximately $4.2 million in the aggregate will
be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from
the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms
of the underwriting agreement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 5 — Commitments and Contingencies</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Registration Rights</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The holders of Founder Shares and Private
Placement Shares that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant
to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company register such securities. In addition, the holders have certain "piggy-back" registration
rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Underwriting Agreement</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The underwriters are entitled to an underwriting
discount of $0.20 per share, or $2,100,000 in the aggregate (or $2,415,000 in the aggregate if the underwriters' over-allotment
option is exercised in full), payable at the Closing of the Proposed Public Offering. $0.35 per share, or $3,675,000 in the aggregate
(or $4,226,250 in the aggregate if the underwriters' over-allotment option is exercised in full) will be payable to the underwriters
for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust
Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Risks and Uncertainties</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Management is currently evaluating the
impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have
a negative effect on the Company's financial position, results of its operations and/or search for a target company, the
specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.</p>
0.20
0.20
2400000
2100000
2415000
0.35
0.35
4200000
3675000
4226250
0.80
393750
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 — Stockholders' Equity</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Class
A Common Stock </i></b>— The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value
of $0.0001 per share. As of September 30, 2020, there were 12,516,500 Class A common stock outstanding, including 11,258,033 Class
A common stock subject to possible conversion were classified as temporary equity in the accompanying balance sheet.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Class
B Common Stock </i></b>— The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of
$0.0001 per share. On June 30, 2020, the Company issued 2,875,000 shares of Class B common stock. On August 11, 2020, the Company
effected a 1:1.05 stock split of the Class B common stock, resulting in an aggregate of 3,018,750 shares of Class B common stock
outstanding, including an aggregate of up to 393,750 shares of Class B common stock that are subject to forfeiture by the Sponsor,
to the Company by the Initial Stockholders for no consideration to the extent that the underwriters' over-allotment option
is not exercised in full or in part, so that the Initial Stockholders would collectively own 20% of the Company's issued
and outstanding common stock (excluding the Private Placement Shares) after the Initial Public Offering (excluding the Private
Placement Shares). All shares and the associated amounts have been retroactively restated to reflect the aforementioned stock
split. On August 14, 2020, the underwriter exercised the over-allotment option; thus, these Founder Shares were no longer subject
to forfeiture.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Holders
of record of Class A common stock and Class B common stock will vote together as a single class on all matters submitted to a
vote of our stockholders, with each share of common stock entitling the holder to one vote except as required by law.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Class B common stock will automatically convert into Class A common stock concurrently with or immediately following the consummation
of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class
A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the
number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted
basis, 20% of the total number of shares of Class A common stock issued and outstanding (excluding the Private Placement Shares)
after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including
the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked
securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial
Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible
into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any private
placement shares issued upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur
on a less than one-for-one basis.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock </i></b>— The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with
such designations, voting and other rights and preferences as may be determined from time to time by the Company's board
of directors. As of September 30, 2020, there were no shares of preferred stock issued or outstanding.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 6 — Stockholder's Equity</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Class A Common Stock </i></b>—
The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of June
30, 2020, there were no shares of Class A common stock issued or outstanding.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Class B Common Stock </i></b>—
The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. On June 30,
2020, the Company issued 2,875,000 shares of Class B common stock. On August 11, 2020, the Company effected a 1:1.05 stock split
of the Class B common stock, resulting in an aggregate of 3,018,750 shares of Class B common stock outstanding, including an aggregate
of up to 393,750 shares of Class B common stock that are subject to forfeiture by the Sponsor, to the Company by the Initial Stockholders
for no consideration to the extent that the underwriters' over-allotment option is not exercised in full or in part, so that
the Initial Stockholders will collectively own 20% of the Company's issued and outstanding common stock (excluding the Private
Placement Shares) after the Proposed Public Offering (excluding the Private Placement Shares). All shares and the associated amounts
have been retroactively restated to reflect the aforementioned stock split.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Holders of record of Class A common stock
and Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders, with each
share of common stock entitling the holder to one vote except as required by law.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Class B common stock will automatically
convert into Class A common stock concurrently with or immediately following the consummation of the initial Business Combination
on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like,
and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked
securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common
stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">number of shares of Class A common stock
issued and outstanding (excluding the Private Placement Shares) after such conversion (after giving effect to any redemptions of
shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued, or
deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the
Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class
A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued,
or to be issued, to any seller in the initial Business Combination and any private placement shares issued upon conversion of Working
Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i>Preferred Stock </i></b>— The
Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting
and other rights and preferences as may be determined from time to time by the Company's board of directors. As of June 30,
2020, there were no shares of preferred stock issued or outstanding.</p>
11258033
393750
12516500
2875000
1:1.05 stock split
0.20
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 — Subsequent Events</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Proposed
Business Combination</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 15, 2020, the Company entered into an agreement and plan of merger (the "Merger Agreement") by and among the
Company, FSG Merger Sub Inc., a Delaware corporation, Gemini Therapeutics, Inc., a Delaware corporation ("Gemini")
and Shareholder Representative Services LLC, a Colorado limited liability company, in its capacity as the representative, agent
and attorney-in-fact of the securityholders of Gemini (in such capacity, the "Stockholders' Representative").
The Merger Agreement provides, among other things, that Merger Sub will merge with and into Gemini, with Gemini surviving as a
wholly owned subsidiary of the Company.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under
the Merger Agreement, subject to customary representations, warranties and covenants, the Company has agreed to acquire all of
the outstanding equity interests of Gemini in exchange for up to 21,500,000 shares of Company Class A common stock, subject to
adjustments, to be paid at the effective time of the Merger. The aggregate number of shares of Class A Common Stock to be issued
in connection with the Merger (including the shares being placed in escrow as described below) will be equal to the difference
between (a) 21,500,000 shares of FSDC Class A Common Stock; minus (b) a number of shares of FSDC Class A Common Stock equal to
one half (1/2) of the initial unallocated shares of the Company's Class A Stock reserved for issuance under the new equity
incentive plan to be adopted by the Company pursuant to the Merger Agreement (which shall not exceed two and one-half percent
(2.5%) of the issued and outstanding shares of the Company's Class A Common Stock as of immediately following the effective
time of the Merger as set forth in the capitalization schedule delivered prior to Closing pursuant to the Merger Agreement (and
approved by the Company, such approval not to be unreasonably withheld, conditioned or delayed)). At or prior to the effective
time of the Merger, each option exercisable for Gemini equity that is outstanding immediately prior to the effective time of the
Merger shall be assumed by the Company and continue in full force and effect on the same terms and conditions as are currently
applicable to such options, subject to adjustments to exercise price and number of shares of Company Class A common stock issued
upon exercise. In addition, the Merger Agreement contemplates that at Closing, the Company will deliver 2,150,000 of its shares
of Class A common stock to be placed into escrow for indemnification purposes, as further described in the Merger Agreement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under
the Merger Agreement, the obligations of the parties to consummate the Merger are subject to the satisfaction or waiver of certain
customary closing conditions of the respective parties, including, without limitation: (i) the approval and adoption of the Merger
Agreement and transactions contemplated thereby by requisite vote of the Company's stockholders (the "Company Stockholder
Approval") and the Gemini's stockholders (the "Gemini Stockholder Approval"); (ii) the receipt of consents
or approvals from the applicable governmental, regulatory or administrative authorities; (iii) the aggregate cash proceeds from
Company's trust account, together with the proceeds from the Subscriptions (as defined below), equaling no less than $170,000,000
(after deducting any amounts paid to Company stockholders that exercise their redemption rights in connection with the Merger
and net of the Company's unpaid liabilities), (iv) the absence of a Material Adverse Effect (as defined in the Merger Agreement)
since the date of the Merger Agreement that is continuing; (v) the Company has not redeemed the Class A of common stock of the
Company in an amount that would cause the Company to have net tangible assets of less than $5,000,001 upon consummation of the
Merger; and (vi) the Company's initial listing application with Nasdaq in connection with the Merger has been conditionally
approved and, immediately following the effective time of the Merger, the Company has satisfied any applicable initial and continuing
listing requirements of Nasdaq, and the Company has not received any notice of non-compliance therewith, and the shares of the
Company's Class A common stock has been approved for listing on Nasdaq. The Company and Gemini have agreed to waive the
condition that the By-Laws of Gemini be approved by the stockholders of the Company.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including,
without limitation, (i) by the Company or Gemini, if (A) the Closing has not occurred by April 15, 2021, which date shall be automatically
extended to May 15, 2021 if the U.S. Securities and Exchange Commission (the "SEC") has not declared the prospectus
effective on or prior to January 15, 2021 and (B) the party (the Company or Merger Sub, on one hand, or Gemini, on the other hand)
seeking to terminate the Merger Agreement is not in material breach of the Merger Agreement; (ii) by the Company or Gemini, in
the event an applicable governmental, regulatory or administrative authority has issued a final and non-appealable order having
the effect of permanently restraining, enjoining or otherwise prohibiting the Merger; (iii) by the Company or Gemini, in the event
any applicable law is in effect making the consummation of the Merger illegal; or (iv) by the Company or Gemini, if the Company
or Gemini, as applicable, has breached any of its respective representations, warranties, agreements or its respective covenants
contained in the Merger Agreement, such failure or breach would render certain conditions precedents to the Closing incapable
of being satisfied, and such breach or failure is not cured by the time allotted.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Merger Agreement contemplates the execution of various additional agreements and instruments, on or before the Closing, including,
among others, the following:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i><u>Parent
Support Agreement</u></i> — In connection with the execution of the Merger Agreement, the Initial Stockholders of the Company
(the "Parent Supporting Stockholders") entered into support agreements with the Company and Gemini (the "Parent
Support Agreements"). Under the Parent Support Agreements, each Parent Supporting Stockholder agreed to vote, at any meeting
of the stockholders of the Company, and in any action by written consent of the stockholders of the Company, all of such Parent
Supporting Stockholder's Class A common stock and Class B common stock (i) in favor of the Merger Agreement, each of the
Parent Proposals (as defined in the Merger Agreement) and the transactions contemplated by the Merger Agreement and the Parent
Support Agreement, and (ii) in favor of any other matter reasonably necessary to the consummation of the transactions contemplated
by the Merger Agreement and the approval of the Parent Proposals. In addition, the Parent Support Agreements prohibit the Parent
Supporting Stockholders from, among other things, selling, assigning or transferring any Class A Common Stock or Class B Common
Stock held by the Parent Supporting Stockholders or taking any action that would prevent or disable the Parent Support Stockholders
from performing its obligations thereunder.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i><u>Gemini
Support Agreement</u></i> — In connection with the execution of the Merger Agreement, certain Gemini stockholders (the "Gemini
Supporting Stockholders") entered into support agreements with the Company (the "Gemini Support Agreements").
Under the Gemini Support Agreements, each Gemini Supporting Stockholder agreed, as promptly as reasonably practicable (and in
any event within two (2) business days) following the SEC declaring effective the</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">prospectus
relating to the approval by the Company stockholders of the Merger, to execute and deliver a written consent with respect to the
outstanding shares of Gemini common stock, Series A preferred stock and Series B preferred stock held by such Gemini Supporting
Stockholder (the "Subject Gemini Shares") approving the Merger Agreement and the transactions contemplated thereby.
In addition to the foregoing, each Gemini Supporting Stockholder agreed that at any meeting of the holders of Gemini capital stock,
each such Gemini Supporting Stockholder will appear at the meeting, in person or by proxy, and cause its Subject Gemini Shares
to be voted (i) to approve and adopt the Merger Agreement and the transactions contemplated thereby, including the Merger (ii)
against any Alternative Transaction (as defined in the Merger Agreement); and (iii) against any action or agreement that would
impede or frustrate the provisions of the Gemini Support Agreements, the Merger Agreement or the transactions contemplated thereby.
Pursuant to the Gemini Support Agreements, certain stockholder agreements of Gemini shall be automatically terminated and of no
further force and effect (other than certain indemnity provisions that, by their terms, survive such termination), effective as
of, and subject to and condition upon the occurrence of, the Closing. In addition, the Gemini Support Agreements prohibits the
Gemini Supporting Stockholders from, among other things, (i) transferring any of the Subject Gemini Shares; (ii) entering into
(a) any option, warrant, purchase right, or other contact that would require the Gemini Support Stockholders to transfer the Subject
Gemini Shares, or (b) any voting trust, proxy or other contract with respect to the voting or transfer of the Subject Gemini Shares;
or (iii) or taking any action in furtherance of the forgoing.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i><u>Subscription
Agreement</u></i> — In connection with the Merger, the Company entered into subscription agreements with certain investors,
including the Sponsor (the "Subscription Agreements"), pursuant to which, among other things, such investors have
agreed to purchase an aggregate of 9,506,000 shares of Class A common stock of the Company (together, the "Subscriptions")
for a purchase price of $10.00 per share, for aggregate gross proceeds of $95,060,000, to be issued at the Closing. The obligations
of each party to consummate the Subscriptions are conditioned upon, among other things, customary closing conditions and the consummation
of the transactions contemplated by the Merger Agreement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Non-Redemption
Agreements</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the execution of the Merger Agreement, certain public stockholders of the Company entered into non-redemption
letter agreements with the Company, pursuant to which, among other things, such stockholders owning shares of Class A Common Stock
agreed not to elect to redeem or tender or submit for redemption 2,742,529 shares of Class A Common Stock held in the aggregate
by such stockholders.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Registration
Rights Agreement</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the Closing, the holders of the Founder Shares, Private Placement Shares and certain other stockholders will enter
into a registration rights agreement with the Company and Gemini, pursuant to which such stockholders can each demand that Gemini
register their registrable securities under certain circumstances and will each also have piggyback registration rights for these
securities. In addition, following the consummation of the business combination, Gemini is required to file and maintain an effective
registration statement under the Securities Act covering such securities and certain other securities of Gemini. The registration
of these securities will permit the public sale of such securities, subject to certain contractual restrictions imposed by such
agreement and the Merger Agreement. As part of the Registration Rights Agreement, holders of the registrable securities agree
to a one hundred eighty (180) day lock-up period with respect to such registrable securities.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Voting
Agreement</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the Closing, the Sponsor, FSDC, certain stockholders of the Company and certain stockholders of Gemini will enter
into a voting agreement, pursuant to which: (a) Gemini will have the right to designate four (4) directors to the board of directors
of Gemini and (b) the Sponsor will have the right to designate one (1) individual for election as a member of the board of directors
of Gemini until the fifth (5th) anniversary of the date of the voting agreement, subject to certain terms and holding requirements
set forth therein.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Lockup
Agreement</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the Closing, certain stockholders of Gemini will enter into a lockup agreement, pursuant to which the stockholder
parties thereto will agree to not (i) sell, hypothecate, pledge, grant any option to purchase or establish or increase a put equivalent
position or liquidate or decrease a call equivalent position or (ii) enter into any swap or other arrangement that transfers any
of the economic consequences of ownership, in each case, of Gemini's common stock for a period of one hundred eighty (180)
days after the Closing.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
above description of the Proposed Business Combination should be read in conjunction with the disclosures contained in the Form
S-4 filed by the Company with the SEC on November 2, 2020.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"> </font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management
has evaluated subsequent events to determine if events or transactions occurring through November 10, 2020, the date the financial
statements were available for issuance, require potential adjustment to or disclosure in the financial statements and has concluded
that all such events that would require recognition or disclosure have been recognized or disclosed.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Note 7 — Subsequent Events</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Subsequent to June 30, 2020, the Company
received $200,000 in loan proceeds under the Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On July 24, 2020, the Sponsor transferred
30,000 Founder Shares to each of its independent director nominees at their original per-share purchase price, for an aggregate
of 90,000 Founder Shares transferred.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On August 11, 2020, the Company effected
a 1:1.05 stock split of the Class B common stock, resulting in the Sponsor holding an aggregate of 2,928,750 Founder Shares and
there being an aggregate of 3,018,750 Founder Shares outstanding. All shares and the associated amounts have been retroactively
restated to reflect the aforementioned stock split.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company evaluated subsequent events
and transactions that occurred after the balance through the date that the financial statements were available to be issued. Based
on this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or
disclosure in the financial statements.</p>
21500000
2150000
21500000
0.025
25000
25000
170000000
95060000
5000001
2742529
200000
30000
90000
9506000
1258467
3018750
3018750
-499411
-1500
-1500
-499411
12075000
120750000
1208
120748792
-7108754
-7108754
4415000
44
4414956
-11258033
-112580330
-1126
-112579204
39489
49914
391999
1500
-190568
-120750000
4415000
122378496
25000
1437928
25000
1000
70000
53000
4226250
113053770
-473440
169570
1489
120750000
200000
2811504
This number includes up to 393,750 shares of Class B common stock subject to forfeiture by our sponsor if the over-allotment option is not exercised in full or in part by the underwriters.
The shares and the associated amounts have been retroactively restated to reflect a 1:1.05 stock split of each outstanding share of Class B common stock in August 2020 (see Note 4).
This number excludes an aggregate of up to 393,750 shares of Class B common stock subject to forfeiture by our sponsor if the over-allotment option is not exercised in full or in part by the underwriters.
The shares and the associated amounts have been retroactively restated to reflect a 1:1.05 stock split of each outstanding share of Class B common stock in August 2020 (see Note 4).